Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy

NCT00070031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: edotecarin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]